Barclays’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-136,346
Closed -$5.14M 4326
2021
Q1
$5.14M Buy
136,346
+124,808
+1,082% +$4.7M ﹤0.01% 1172
2020
Q4
$196K Sell
11,538
-195,665
-94% -$3.32M ﹤0.01% 2707
2020
Q3
$973K Buy
207,203
+187,945
+976% +$883K ﹤0.01% 1943
2020
Q2
$117K Sell
19,258
-2,616
-12% -$15.9K ﹤0.01% 3051
2020
Q1
$50K Sell
21,874
-23,659
-52% -$54.1K ﹤0.01% 3109
2019
Q4
$209K Buy
45,533
+14,287
+46% +$65.6K ﹤0.01% 3155
2019
Q3
$121K Sell
31,246
-2,207
-7% -$8.55K ﹤0.01% 3304
2019
Q2
$201K Buy
33,453
+11,526
+53% +$69.3K ﹤0.01% 3196
2019
Q1
$294K Buy
21,927
+6,079
+38% +$81.5K ﹤0.01% 2860
2018
Q4
$147K Sell
15,848
-22,506
-59% -$209K ﹤0.01% 2832
2018
Q3
$534K Buy
38,354
+33,584
+704% +$468K ﹤0.01% 2601
2018
Q2
$75K Sell
4,770
-20,677
-81% -$325K ﹤0.01% 3177
2018
Q1
$437K Buy
25,447
+18,414
+262% +$316K ﹤0.01% 2376
2017
Q4
$154K Sell
7,033
-3,082
-30% -$67.5K ﹤0.01% 2798
2017
Q3
$413K Buy
10,115
+866
+9% +$35.4K ﹤0.01% 2018
2017
Q2
$278K Sell
9,249
-6,295
-40% -$189K ﹤0.01% 2256
2017
Q1
$562K Buy
15,544
+7,854
+102% +$284K ﹤0.01% 1886
2016
Q4
$385K Buy
7,690
+2,718
+55% +$136K ﹤0.01% 1971
2016
Q3
$261K Buy
4,972
+2,794
+128% +$147K ﹤0.01% 2004
2016
Q2
$91K Sell
2,178
-65,869
-97% -$2.75M ﹤0.01% 2380
2016
Q1
$2.72M Buy
68,047
+25,425
+60% +$1.02M ﹤0.01% 950
2015
Q4
$1.75M Buy
42,622
+31,174
+272% +$1.28M ﹤0.01% 1121
2015
Q3
$172K Buy
11,448
+6,551
+134% +$98.4K ﹤0.01% 2181
2015
Q2
$118K Buy
4,897
+3,895
+389% +$93.9K ﹤0.01% 2295
2015
Q1
$23K Buy
1,002
+20
+2% +$459 ﹤0.01% 3062
2014
Q4
$27K Buy
982
+416
+73% +$11.4K ﹤0.01% 3307
2014
Q3
$6K Buy
566
+229
+68% +$2.43K ﹤0.01% 3922
2014
Q2
$5K Sell
337
-38
-10% -$564 ﹤0.01% 3907
2014
Q1
$7K Buy
375
+284
+312% +$5.3K ﹤0.01% 3914
2013
Q4
$1K Buy
+91
New +$1K ﹤0.01% 4277